A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
Clinical trial NCT04348175 · COMPLETED
Trial details
- NCT number
- NCT04348175
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2021-04-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.